Skip to content

RoosterBio

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • High Volume hMSCs
      • XF hBM-MSCs
      • XF hUC-MSCs
      • XF RTP hBM-MSCs
      • Traditional hBM-MSCs
      • Traditional RTP hBM-MSCs
    • hMSC Bioprocess Media
      • XF hMSC Bioprocess Media
      • XF hMSC Bioreactor Feeds
      • XF hMSC Bioprocess Supplements & Reagents
      • Traditional hMSC Bioprocess Media
    • CliniControl Products
      • CliniControl High Volume hMSCs
      • CliniControl hMSC Bioprocess Media
      • CliniControl Extracellular Vesicle (EV) Production
    • Extracellular Vesicle (EV) Production
      • EV Collection Media
      • EV Supplements & Reagents
    • hMSC Kits
      • RoosterVial & RoosterNourish Test Kits
      • Donor Screening Test Kits
      • Bioreactor Starter Kits
      • Bioreactor Development Kits
      • Bioprinting Kits
      • Bioprinting RTP Kits
  • Services
    • Process Development Services
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Search Publications

Therapeutic Indication

Tech Segment

Reset
Collagen Hydrogel Scaffold Promotes Mesenchymal Stem Cell and Endothelial Cell Coculture for Bone Tissue Engineering
February 2017 Bioprocess Tool Development, Orthopedic, Tissue & Organ Engineering

Collagen Hydrogel Scaffold Promotes Mesenchymal Stem Cell and Endothelial Cell Coculture for Bone Tissue Engineering

Deformability of Human Mesenchymal Stem Cells Is Dependent on Vimentin Intermediate Filaments
January 2017 Bioprocess Tool Development, Cell Therapy

Deformability of Human Mesenchymal Stem Cells Is Dependent on Vimentin Intermediate Filaments

Particle aggregates formed during furfuryl methacrylate plasma polymerization affect human mesenchymal stem cell behaviour
January 2019 Bioprocess Tool Development

Particle aggregates formed during furfuryl methacrylate plasma polymerization affect human mesenchymal stem cell behaviour

Microfluidic label-free selection of mesenchymal stem cell subpopulation during culture expansion extends the chondrogenic potential in vitro
March 2018 MedTech, Devices, & Materials, Orthopedic, Tissue & Organ Engineering

Microfluidic label-free selection of mesenchymal stem cell subpopulation during culture expansion extends the chondrogenic potential in vitro

Morphological Features of IFN-γ-stimulated Mesenchymal Stromal Cells Predict Overall Immunosuppressive Capacity
March 2017 Cell Therapy, Immunomodulation

Morphological Features of IFN-γ-stimulated Mesenchymal Stromal Cells Predict Overall Immunosuppressive Capacity

Enhanced Non-viral Gene Delivery by Coordinated Endosomal Release and Inhibition of β-tubulin Deactylase
April 2017 Gene Editing, Immunomodulation

Enhanced Non-viral Gene Delivery by Coordinated Endosomal Release and Inhibition of β-tubulin Deactylase

Tubulogenesis of Co-cultured Human iPS-derived Endothelial Cells and Human Mesenchymal Stem Cells in Fibrin and Gelatin Methacrylate Gels
July 2017 Cardiovascular, Tissue & Organ Engineering

Tubulogenesis of Co-cultured Human iPS-derived Endothelial Cells and Human Mesenchymal Stem Cells in Fibrin and Gelatin Methacrylate Gels

Tissue Source and Cell Expansion Condition Influence Phenotypic Changes of Adipose-Derived Stem Cells
August 2017 Cell Therapy, Dermal and Wound

Tissue Source and Cell Expansion Condition Influence Phenotypic Changes of Adipose-Derived Stem Cells

Silk fibroin/collagen protein hybrid cell-encapsulating hydrogels with tunable gelation and improved physical and biological properties
March 2019 MedTech, Devices, & Materials, Tissue & Organ Engineering

Silk fibroin/collagen protein hybrid cell-encapsulating hydrogels with tunable gelation and improved physical and biological properties

Cells as Advanced Therapeutics: State-of-the-art, Challenges, and Opportunities in Large Scale Biomanufacturing of High-quality Cells for Adoptive Immunotherapies
May 2017 Bioprocess Tool Development

Cells as Advanced Therapeutics: State-of-the-art, Challenges, and Opportunities in Large Scale Biomanufacturing of High-quality Cells for Adoptive Immunotherapies

Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next

Careers

Contact Us

Contact Information

RoosterBio, Inc.
Email: info@roosterbio.com Phone: +1 301-200-5366

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn
  • Email

Copyright © 2021 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Wood Street, Inc.